Scientists Use 3D Printing To Create New Stem Cells For Kidney Health - The Healing Miracle

Scientists Use 3D Printing To Create New Stem Cells For Kidney Health

Nov 5, 2019

Organovo, a bioprinting company, has submitted a new report regarding a new stem-cell-based process to create kidney tissue using the NovoGen Bioprinter, a 3D bioprinting platform. New data was released showing how the company manufactured complex kidney organoids in The International Society for Stem Cell Research in Los Angeles, California, with the hope of future in-vitro modeling and possible treatments for patients suffering from renal disease.

The CEO of Organovo, Taylor Crouch, says that collaborative effort between world-class institutions can lead towards accelerated work in implantable tissues and finding cures for critical diseases. Crouch further stated that the company’s partnership with Murdoch Research Institute and the head of Kidney Research at MCRI, Melissa Little made producing kidney organoids possible. Combining the 3D bioprinter with the lab’s proprietary stem cell modeling paved the way for detailed kidney tissues to be made, advancing the technology needed for therapeutic applications and drug testing. Crouch believes that it’s an important step towards successfully treating patients with kidney disease.

According to the report, the differentiation of embryonic stem cells to kidney organoids can mean improvement towards disease modeling, renal function restoration and drug screening via patient-derived stem cells.

Organovo claims to have had successes in regards to replicating the differentiation protocol and putting it on the NovoGen 3D Bioprinter for rapid and automated fabrication of the organoids. Tests showed that the bioprinted material was similar to those created via manual generation at component cell type and morphology level, and expression profiles as well. Toxicity screening was made possible by using 96-well plates that had a classic nephrotoxic compound. Results showed that the bio-printed kidneys were equal to those that were manually prepared in terms of function, and as such can be used in a variety of applications. Moreover, a bioprinter gave the company the ability to produce uniform quantities of reproducible organoids sooner than manual processes.

Reporter and control iPSC lines dictated the kidney organoid’s character and showed increasing tubular complexity at 800um on the scale bar.

In short, 3D bioprinting has made it possible to produce iPSC, or human induced pluripotent stem cells, and turn it into organoid kidneys that have the same gene expression, identity and cellular complexity as that of manually-generated ones. The inclusion of a bioprinter allows for faster production without compromising the material’s quality. The organoid kidneys may be used to further fields of research, including human development modeling, in-vitro disease and drug testing while providing promise for future tissue engineering processes and stem cell therapy for treating patients suffering from renal disease.

Organizations around the globe are actively pushing for the development of bioprinting in hopes of getting tangible results that can be applied to patients over the next few years. In fact, researchers and bioprinting companies are all working towards creating solutions to treat conditions such as renal disease and failure. The GBD, or Global Burden of Disease, has revealed that there was an increase of people dying from kidney failure, up 32 percent since 2005 and now numbering 1.2 million individuals. Furthermore, it was believed that up to 7.1 million people died from end-stage kidney disease without getting chronic dialysis treatment, and about 10 million die each year due to kidney disease.

The biotech firm has expressed interest in developing 3D-printed tissues with human application in mind for about 10 years and running. Organovo first focused on looking for a solution to liver disease and started looking at IND-track programs for their NovoTissues in order to address chronic and unmet medical needs by traditional healthcare industry. The firm’s program in 2017 was to address Alpha-1 antitryspin deficiency, which received FDA orphan drug designation and gave the company access to the in-vitro tissue platform with high value drug discovery in mind. Organovo’s commitment to advanced medical care is largely concentrated on kidney tissue; the firm has released a large number of data regarding their work on 3D printed tissues for testing and research purposes in the last 5 years. Advancing personalized patient care and regenerative medicine should address challenges the world is currently facing with its aged population. Evolving healthcare needs on traditional platforms is not enough- medical advances such as the one Organovo offers may in the future save lives and make healthcare costs more affordable and therefore more accessible to everyone who needs it.


To your health,

The Healing Miracle Team

Did you enjoy this article?

Share your own experiences below!


Submit a Comment

Your email address will not be published. Required fields are marked *

Stem Cell Therapy Breaks Baseball’s Tommy John Epidemic

Stem Cell Therapy Breaks Baseball’s Tommy John Epidemic

For more than 50 years baseball players in both small and big leagues regularly have received stem cell therapy to reverse damage and injuries sustained while playing the game, though it's rarely discussed or told in the open. Then in 2016 the Los Angeles Angels broke...

A New Anti-Cancer Combination Against Glioblastoma

A New Anti-Cancer Combination Against Glioblastoma

Researchers have found a way to eliminate two major cell types in aggressive brain cancer - by combining a special diet with a drug that fights off tumors. The team details that they used an antibiotic with a high-fat, low carbohydrate diet to destroy mesenchymal and...

© 2019 The Healing Miracle. All Rights Reserved.
Terms & Conditions | Privacy Policy


Information on this web site is provided for informational purposes only. The information is a result of years of practice experience by the author. This information is not intended as a substitute for the advice provided by your physician or other healthcare professional or any information contained on or in any product label or packaging. Do not use the information on this web site for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or homeopathic supplement, or using any treatment for a health problem. If you have or suspect that you have a medical problem, contact your health care provider promptly. Do not disregard professional medical advice or delay in seeking professional advice because of something you have read on this web site. Information provided on this web site and the use of any products or services purchased from our web site by you DOES NOT create a doctor-patient relationship between you and any of the physicians affiliated with our web site. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

Pin It on Pinterest

Share This